M. Takahashi

Use of dominant negative mutants of the hepadnaviral core protein as antiviral agents

J. Wands, P. Scaglioni, M. Melegari, 1995, Hepatology.

A novel strategy for in vivo expansion of transplanted hepatocytes using preparative hepatic irradiation and FasL-induced hepatocellular apoptosis

B. Vikram, C. Guha, J. Roy-Chowdhury, 2003, Gene Therapy.

Hexamethylene bisacetamide can convert nonpermissive human cells to a permissive state for expressing the major immediate-early genes of human cytomegalovirus by up-regulating NF-kappaB activity.

M. Yasuda, H. Sadanari, J. Tanaka, 2009, Virology.

Liver-directed gene therapy: promises, problems and prospects at the turn of the century.

N. Chowdhury, J. Chowdhury, B. Parashar, 2000, Journal of hepatology.

Local and systemic responses following intravitreous injection of AAV2-encoded modified Volvox channelrhodopsin-1 in a genetically blind rat model

M Tamai, E. Sugano, H. Tomita, 2015, Gene Therapy.

Induction of central tolerance by intrathymic inoculation of adenoviral antigens into the host thymus permits long-term gene therapy in Gunn rats.

M. Horwitz, N. Chowdhury, J. Chowdhury, 1996, The Journal of clinical investigation.

Enhanced therapeutic efficacy of G207 for the treatment of glioma through Musashi1 promoter retargeting of γ34.5-mediated virulence

H. Okano, S. Goldman, T. Kawase, 2006, Gene Therapy.